Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/1078-0432.CCR-25-0070 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Therapeutic Drug Monitoring for Precision Dosing of Janus Kinase Inhibitors: Protocol for a Prospective Observational Study.
JMIR Res Protoc
September 2025
Service of Clinical Pharmacology, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Background: Janus kinase inhibitors (JAKIs) are small molecules used orally to treat inflammatory and hematological disorders. They have demonstrated impressive efficacy across multiple indications. However, concerns have emerged regarding their safety profile.
View Article and Find Full Text PDFHidden threat: The high-efficacy herbicidal R-NAP isomer drives heavy metal accumulation in plants via growth stimulation and coordination of metal transporters.
J Environ Manage
September 2025
Zhejiang Collaborative Innovation Center for Full-Process Monitoring and Green Governance of Emerging Contaminants, Key Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province, Interdisciplinary Research Academy (IRA), Zhejiang Shuren University, Hangzhou, 310015, China. Electr
The widespread coexistence of chiral herbicides and heavy metals (HMs) in agricultural soils poses significant ecological risks to crop safety, yet their combined ecotoxicological effects are not well understood. This study systematically investigated the enantiomer-specific effects of napropamide (R/S-NAP) on plant HMs accumulation. Results showed that S-NAP application reduced plant biomass and HMs accumulation, while R-NAP exhibited distinct effects, increasing root biomass and HMs accumulation in roots.
View Article and Find Full Text PDFOver twenty-five years of ketogenic diet therapy: Supporting children and adults with drug-resistant epilepsy using nutritionally complete ketogenic formulations: A scoping review.
Epilepsy Behav
September 2025
Danone Research & Innovation, Uppsalalaan 12, 3584 CT Utrecht, the Netherlands. Electronic address:
Purpose: Ketogenic diet therapy (KDT) has been successfully used as an effective management option for drug resistant epilepsy (DRE) since the 1920 s. The ketogenic formulation studied here (KetoCal) is nutritionally complete, very high in fat, and low in carbohydrates and has played a crucial role in supporting the implementation of KDT for over twenty-five years. This scoping review aims to synthesise the existing literature regarding the safety, acceptability, and efficacy of the ketogenic formulation in supporting the management of DRE.
View Article and Find Full Text PDFThermal ecology and swimming performance of native tadpoles Dryophytes femoralis in central Florida.
J Therm Biol
September 2025
Department of Integrative Biology, University of South Florida, St. Petersburg, FL, USA. Electronic address:
Urbanization and climate warming have contributed to global amphibian declines in recent decades, and amphibians are particularly vulnerable to warming because temperature influences their physiological processes across all life stages. Tadpole responses to warming in tropical climates are relatively understudied, and previous studies demonstrated species-specific responses to warming temperature. Warming ponds may quicken tadpole development and increase thermal tolerances, but increasing local temperatures push populations towards their physiological limits.
View Article and Find Full Text PDFLong-Term Open-Label Study Evaluating Oral Miglustat Treatment in Patients With Neuronal Ceroid Lipofuscinosis Type 3.
Neurology
October 2025
Neurology, Epilepsy and Movement Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, Full Member of European Reference Network on Rare and Complex Epilepsies - EpiCARE, Rome, Italy.
Objectives: Neuronal ceroid lipofuscinosis type 3 (CLN3) is a rare lysosomal storage disorder characterized by progressive neurodegeneration. No disease-modifying treatments are currently available. Miglustat, a substrate reduction therapy, has shown preclinical efficacy in CLN3 models (conference abstract).
View Article and Find Full Text PDF